Home  »  Trending   »  Hims & Hers Health Inc. (HIMS) and the Battle...

Hims & Hers Health Inc. (HIMS) and the Battle of Fundamentals vs. Technicals

Hims & Hers Health Inc. (NYSE:HIMS) went down by -0.61% from its latest closing price compared to the recent 1-year high of $9.35. The company’s stock price has collected 6.75% of gains in the last five trading sessions.

Is It Worth Investing in Hims & Hers Health Inc. (NYSE :HIMS) Right Now?

Opinions of the stock are interesting as 4 analysts out of 8 who provided ratings for Hims & Hers Health Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 3 rated it as “hold,” and 1 as “sell.”

Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now. .


The average price from analysts is $6.31, which is -$0.17 below the current price. HIMS currently public float of 154.24M and currently shorts hold a 7.98% ratio of that float. Today, the average trading volume of HIMS was 2.34M shares.

HIMS’s Market Performance

HIMS stocks went up by 6.75% for the week, with a monthly jump of 25.34% and a quarterly performance of 48.97%, while its annual performance rate touched -20.10%. The volatility ratio for the week stands at 5.18% while the volatility levels for the past 30 days are set at 6.16% for Hims & Hers Health Inc. The simple moving average for the period of the last 20 days is 11.31% for HIMS stocks with a simple moving average of 19.92% for the last 200 days.

Analysts’ Opinion of HIMS

Many brokerage firms have already submitted their reports for HIMS stocks, with SVB Leerink repeating the rating for HIMS by listing it as a “Underperform.” The predicted price for HIMS in the upcoming period, according to SVB Leerink is $4 based on the research report published on July 15th of the current year 2022.

Guggenheim, on the other hand, stated in their research note that they expect to see HIMS reach a price target of $10. The rating they have provided for HIMS stocks is “Buy” according to the report published on April 14th, 2022.

Credit Suisse gave a rating of “Outperform” to HIMS, setting the target price at $8 in the report published on April 01st of the current year.

HIMS Trading at 33.39% from the 50-Day Moving Average

After a stumble in the market that brought HIMS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -30.70% of loss for the given period.

Volatility was left at 6.16%, however, over the last 30 days, the volatility rate increased by 5.18%, as shares surge +15.51% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +83.57% upper at present.

During the last 5 trading sessions, HIMS rose by +6.75%, which changed the moving average for the period of 200-days by -18.59% in comparison to the 20-day moving average, which settled at $5.86. In addition, Hims & Hers Health Inc. saw -1.07% in overturn over a single year, with a tendency to cut further losses.

Insider Trading

Reports are indicating that there were more than several insider trading activities at HIMS starting from Becklund Irene, who sale 19,331 shares at the price of $5.00 back on Jul 05. After this action, Becklund Irene now owns 13,717 shares of Hims & Hers Health Inc., valued at $96,655 using the latest closing price.

O’Keefe Lynne Chou, the Director of Hims & Hers Health Inc., sale 10,045 shares at $4.35 during a trade that took place back on Jun 21, which means that O’Keefe Lynne Chou is holding 0 shares at $43,696 based on the most recent closing price.

Stock Fundamentals for HIMS

Current profitability levels for the company are sitting at:

  • -42.31 for the present operating margin
  • +73.72 for the gross margin

The net margin for Hims & Hers Health Inc. stands at -39.60. Equity return is now at value -22.10, with -18.50 for asset returns.

The liquidity ratio also appears to be rather interesting for investors as it stands at 3.41.